Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness

UMEC/VI as 62.5/25 mcg, which is a once-daily single inhaler dual therapy, given to subjects, via Ellipta .

FLUT/SAL as 250/50 mcg, which is a twice-daily single inhaler dual therapy, given to subjects, via Diskus.

Questionnaire used to asses Condition-related well-being, for COPD subjects.

Questionnaire used to asses Breathlessness, due to Dyspnea, for COPD subjects.

It is a single once daily, Dry powder Inhaler (DPI), developed for delivery of therapies in COPD subjects.

It is a plastic device containing twice-daily single inhaler dual therapy, developed for delivery of therapies in COPD subjects.